Northwestern Mutual Wealth Management CO Hutchmed (China) LTD Transaction History

Northwestern Mutual Wealth Management CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$12.08 - $18.56 $410 - $631	34 New	34 $0
Q4 2022 Feb 21, 2023	BUY	$7.65 - $15.51 $53 - $108	7 New	7 $0
Q1 2022 May 09, 2022	SELL	$15.52 - $35.65 $698 - $1,604	-45 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$35.66 - $42.94 $1,604 - $1,932	45 New	45 $2,000
Q2 2021 Aug 13, 2021	SELL	$23.7 - $39.27 $592 - $981	-25 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$27.01 - $36.8 $675 - $919	25 New	25 $1,000

8.25M

3.8K

2.4K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $3.11B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.